Abstract:Background The most common type of kidney cancer that easily metastasizes is clear cell renal cell carcinoma (ccRCC). The expression levels of hyaluronan-mediated motility receptor (HMMR) in many tumor types are significantly enhanced. HMMR is closely associated with tumor-related progression, treatment resistance, and discouraging prognosis, has yet to be fully investigated in terms of its expression patterns and molecular mechanisms of action in ccRCC. Further research is imperative to elucidate these aspects. Methods We used The Cancer Genome Atlas (TCGA) database to preliminarily investigate HMMR expression and function in ccRCC. We assessed the differential expression level of HMMR between ccRCC cancerous tissues and their matched non-tumor tissues. Subsequently, a series of in vivo and in vitro experiments were designed to elucidate the biological function of HMMR in ccRCC, including Transwell migration assays, CCK-8 assays, clone formation assays and subcutaneous xenograft experiments in nude mice. Through bioinformatics analysis, we identified potential microRNAs (miRNAs) that may regulate HMMR, as well as the possible signaling pathways involved. Finally, we conducted a series of cellular functional experiments to validate our hypotheses regarding the HMMR axis. Results HMMR expression was observably up-regulated in tumor tissues of ccRCC patients, and elevated HMMR expression level showed a strong correlation with ccRCC progression and adverse prognoses of patients. Knocking down HMMR inhibited the proliferative and migratory abilities of ccRCC cells, while its overexpression amplified these oncogenic properties. In nude mouse model, reduced HMMR expression inhibited ccRCC tumor proliferation in vivo. Furthermore, overexpression of an upstream transcriptional regulator, miR-9-5p, effectively downregulated HMMR expression and thus impeded ccRCC cells proliferation and migration. In addition, HMMR might influence ccRCC growth via the Epithelial-Mesenchymal Transition (EMT) pathway and the Janus Kinase1/Signal Transducer and Activator of Transcription1 (JAK1/STAT1) pathway. Conclusions HMMR is overexpressed in ccRCC, and there is a significant link between high HMMR expression and tumor progression, as well as poor patient prognosis. Specifically, HMMR could be targeted and inhibited by miR-9-5p and might modulate the tumorigenesis and progression of ccRCC through both EMT and JAK1/STAT1 signaling pathway.

Activation of Toll-Like Receptor-9 Promotes Cellular Migration Via Up-Regulating MMP-2 Expression in Oral Squamous Cell Carcinoma

MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression Via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer.

Toll-like Receptor-9 Agonists Increase Cyclin D1 Expression Partly Through Activation of Activator Protein-1 in Human Oral Squamous Cell Carcinoma Cells.

Mir-9-5p/hmmr Regulates the Tumorigenesis and Progression of Clear Cell Renal Cell Carcinoma Through EMT and JAK1/STAT1 Signaling Pathway

Increased Expression of Toll-like Receptor-9 Has Close Relation with Tumour Cell Proliferation in Oral Squamous Cell Carcinoma.

Regulation Of Migration And Invasion By Toll-Like Receptor-9 Signaling Network In Prostate Cancer

Toll-Like Receptor 9 Agonist Inhibits Er Alpha-Mediated Transactivation by Activating Nf-Kappa B in Breast Cancer Cell Lines

TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell in Vivo

Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis.

Functional Expression of TLR9 is Associated to the Metastatic Potential of Human Lung Cancer Cell

CpG Oligonucleotides Activating Toll-Like Receptor 9 Promotes Invasion of Breast Cancer Cells

Angiogenesis , Metastasis , and the Cellular Microenvironment CXCR 4 Promotes Oral Squamous Cell Carcinoma Migration and Invasion through Inducing Expression of MMP-9 and MMP-13 via the ERK Signaling Pathway

CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.

The Secretion of IL-6 by CpG-ODN-treated Cancer Cells Promotes T-cell Immune Responses Partly Through the TLR-9/AP-1 Pathway in Oral Squamous Cell Carcinoma

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

TGF-β/TβR1 Pathway Induces Head and Neck Squamous Cell Carcinoma Cells Invasion Through the Up-Regulation of MMP2

MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway

Toll-like receptor 9 in tumorigenesis and tumor therapy

Research Progress of TLR9 Inherent Signaling Pathways in Tumor Cells

Functional expression of TLR9 in esophageal cancer

Activation of Toll-Like Receptor 3 Induces Apoptosis of Oral Squamous Carcinoma Cells in Vitro and in Vivo